Skip Navigation
Menu

Contribute to Meaningful Advances That Benefit Patients in Need

1979

Nurse’s Aide in Intensive Care Oncology Unit.

1988

Intensive Care Clinical Nurse in Oncology ICU participating in clinical trial data collection for phase I, II, and III studies.

1998

Director at several biopharmaceutical companies. Coordinated large clinical studies that spanned 6 continents, 30 countries, and 200 sites related to phase III sepsis and inflammatory disease studies.

2006

Co-founder of a specialty pharmaceutical company focusing on developing orphan indication products.

2014

Vice President of Integrated Product Development, leading a team of global regulatory affairs experts to help clients develop products more quickly and reach patients in need.

PAREXEL Recognized as a 2015 “Training Top 125” by Training Magazine

Company acknowledged for excellence in employer-sponsored training and development programs

Boston, MA, February 10, 2015 — PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced it has been recognized among top U.S. businesses in Training magazine’s annual “Training Top 125.” PAREXEL earned a place in the ranking this year for developing creative and effective employee learning and development initiatives for their global workforce.

“From traditional instructor-led settings to eLearning environments, PAREXEL provides best-in-class learning products and customized training programs to present employees with valuable career and job skills development,” said Albert Siu, Vice President, Learning and Development, PAREXEL. “In the highly complex and regulated drug development environment, having expertly trained employees around the globe is an essential element to help our clients simplify their journey toward bringing new drugs to market for patients.”

PAREXEL’s comprehensive learning and training programs encompass four primary learning domains including: company culture and strategy; functional competencies; leadership development; and professional development. The Company’s standardized instructional design model ensures training programs address the complexities of global clinical trial requirements today, with each program featuring a unique set of performance metrics to measure operational and training effectiveness across the learning disciplines.

“PAREXEL impressed us with its focus on delivering ‘the right training, to the right people, at the right time’ to ensure its employees are prepared to succeed in their jobs and careers,” said Lorri Freifeld, editor-in-chief, Training magazine. “The competition was fierce this year, and PAREXEL’s global learning and development initiatives earned it this well-deserved spot in our 2015 ranking.”

In addition to training employees, PAREXEL is committed to developing the future, global biopharmaceutical workforce with courses specifically tailored to meet the growing talent needs of the clinical development job market.  Since 2001, the PAREXEL Academy has designed and implemented a wide-range of learning and performance programs tailored to enable clinical research management practices for learners outside of PAREXEL. The PAREXEL Academy has locations in the United States, Europe, and Asia. 

For the last 15 years, Training magazine, the leading business publication for learning and development professionals, has issued its annual “Training Top 125,” which ranks companies’ excellence in employer-sponsored training and development programs. The ranking is based on myriad benchmarking statistics such as total training budget; percentage of payroll; number of training hours per employee program; goals, evaluation, measurement of outcomes and impact, and workplace surveys; hours of training per employee annually; and detailed formal programs.  

Sign Up for Alerts

Get the latest PAREXEL career opportunities as soon as they become available.

Saved Jobs

You have not saved any jobs.

View all jobs

Recently Viewed Jobs

You have not recently viewed any jobs

View all jobs